Valuation dashboard for Inotiv, Inc. (NOTV) with P/E N/A, P/B 0.04, EV/EBITDA 46.61 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
Analysis Summary
Inotiv, Inc. reported revenue of $513.0M in the most recent fiscal year, growing at a 5-year CAGR of 53.4%.
Trailing-twelve-month margins: gross margin 14.7%, operating margin -8.9%, net margin -17.1%.
At the current price of $0.08, NOTV has negative trailing earnings (P/E not meaningful) and an ROE of -74.67%. Market capitalisation stands at $3M.
Balance sheet quality for NOTV: current ratio of 0.3. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.04 |
| EV / EBITDA | 46.61 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NOTV | Inotiv, Inc. | $3M | 0.04 | -74.7% | |
| TMO | Thermo Fisher Scientific Inc. | $241.0B | 36.16 | 4.74 | 13.4% |
| 0R0H.L | Thermo Fisher Scientific Inc. | $225.7B | 32.73 | 4.11 | 12.6% |
| 0R2B.L | Danaher Corporation | $142.2B | |||
| DHR | Danaher Corporation | $140.6B | 37.04 | 2.81 | 7.7% |
| 0HAV.L | Agilent Technologies, Inc. | $49.3B | 30.43 | 5.93 | 20.5% |
| NTRA | Natera, Inc. | $46.7B | 27.16 | -12.2% | |
| IQV | IQVIA Holdings Inc. | $44.2B | 34.40 | 7.58 | 20.9% |
Price
| Price | $0.08 |
| Market Cap | $3M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -74.67% |
| Return on Invested Capital | -6.25% |
| Return on Assets | -12.38% |
| Gross Margin | 14.70% |
| Operating Margin | -8.87% |
| Net Margin | -17.14% |
Related companies: BDSX · BEAT · BIAF · CELU · FGEN · KZR · QNTM
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of NOTV: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks